Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neoplasm, Residual × Letrozole × Clear all

Sponsor

Conditions

Breast Neoplasms 113 Neoplasm Metastasis 5 Carcinoma, Intraductal, Noninfiltrating 5 Polycystic Ovary Syndrome 4 Osteoporosis 4 Neoplasms 4 Infertility 4 Breast Neoplasms, Male 4 Arthralgia 4 Ovarian Neoplasms 3 Fallopian Tube Neoplasms 3 Triple Negative Breast Neoplasms 2 Pain 2 Leiomyosarcoma 2 Leiomyoma 2 Endometrial Neoplasms 2 Cystadenocarcinoma, Serous 2 Breast Carcinoma In Situ 2 Bone Diseases, Metabolic 2 Uterine Neoplasms 1 Recurrence 1 Ovarian Cysts 1 Osteitis Deformans 1 Obesity 1 Multiple Endocrine Neoplasia Type 1 1 Medullary cystic kidney disease 1 1 Lymphoma, Non-Hodgkin 1 Lymphangioleiomyomatosis 1 Lethal Congenital Contracture Syndrome 2 1 Hormone-sensitive Metastatic Breast Cancer 1

Interventions

Rituximab 4 blinatumomab 3 Whole-Body Irradiation 3 Cyclophosphamide 3 fludarabine phosphate 2 Mycophenolic Acid 2 Melphalan 2 Lenalidomide 2 Clofarabine 2 treosulfan 1 thymoglobulin 1 sabatolimab 1 pembrolizumab 1 peginterferon alfa-2a 1 obinutuzumab 1 midostaurin 1 ixazomib 1 fludarabine 1 eribulin 1 daratumumab 1 acalabrutinib 1 Trastuzumab 1 Tacrolimus 1 Sodium Chloride 1 Sirolimus 1 Peripheral Blood Stem Cell Transplantation 1 Pentostatin 1 N,N-dicyclohexyl-isoborneol-10-sulfonamide 1 Methotrexate 1 Magnetic Resonance Imaging 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡